Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Non-cash Items (2020 - 2025)

Historic Non-cash Items for Insight Molecular Diagnostics (IMDX) over the last 4 years, with Q3 2025 value amounting to $518000.0.

  • Insight Molecular Diagnostics' Non-cash Items rose 12620.09% to $518000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $518000.0, marking a year-over-year increase of 12620.09%. This contributed to the annual value of $246000.0 for FY2024, which is N/A changed from last year.
  • Insight Molecular Diagnostics' Non-cash Items amounted to $518000.0 in Q3 2025, which was up 12620.09% from $390000.0 recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Non-cash Items registered a high of $19.1 million during Q4 2021, and its lowest value of $51.0 during Q2 2024.
  • Moreover, its 3-year median value for Non-cash Items was $262500.0 (2024), whereas its average is $2.6 million.
  • Within the past 5 years, the most significant YoY rise in Insight Molecular Diagnostics' Non-cash Items was 76460588.24% (2025), while the steepest drop was 4455.96% (2025).
  • Quarter analysis of 3 years shows Insight Molecular Diagnostics' Non-cash Items stood at $19.1 million in 2021, then tumbled by 98.71% to $246000.0 in 2024, then surged by 110.57% to $518000.0 in 2025.
  • Its Non-cash Items stands at $518000.0 for Q3 2025, versus $390000.0 for Q2 2025 and $279000.0 for Q1 2025.